• BS Biology, Economics | Duke University 2001
  • MD | Harvard 2007
  • Residency | Harvard 2012
  • Clinical Focus | Central Nervous System Tumors, Stereotactic Radiosurgery, Breast Cancer, Proton Therapy

Dr. Hattangadi-Gluth is a Professor and Assistant Vice-Chair of Faculty Climate and Development. She is the Central Nervous System (CNS) Tumor Section Chief and Director of the CNS Tumor Program at the California Proton Center. She is the Deputy Director of the Center for Precision Radiation Medicine in the Center for Precision Radiation Medicine (CPRM) within the Altman Clinical & Translational Research Institute (ACTRI) and Co-Lead of the CNS Disease Team at the UC San Diego Moores Cancer Center. In addition, she is also an active member of the RMAS Breast Cancer Disease Team.

A nationally-recognized expert in the treatment of patients with brain tumors, she serves on the National Comprehensive Cancer Network (NCCN) panel for the treatment of CNS malignancies. Dr. Hattangadi-Gluth is the Chair of the CNS Tumor Track of the American Society of Radiation Oncology (ASTRO) Education Committee and Co-Chair of the CNS Track of the ASTRO Scientific Committee. Since 2014, Dr. Hattangadi-Gluth has been a member of the Board of Directors of the San Diego Brain Tumor Foundation and has been repeatedly recognized as a Top Doctor by the San Diego Magazine.

Her research focuses on the use of advanced imaging techniques (MRI-based) and quantitative methods to improve radiation therapy planning and delivery, and to analyze response to radiation in brain tissue. At UC San Diego, she received a KL2 Career Development Award from the NIH/CTRI (Clinical and Translational Research Institute), and now she is the recipient and principal investigator (PI) of a prestigious NIH/NCI R-01 Grant evaluating image-guided cognitive-sparing radiosurgery. Dr. Hattangadi-Gluth is also PI on several investigator-initiated clinical trials, including a longitudinal study of advanced diffusion imaging and serial neurocognitive testing to measure radiation-induced injury in brain tumor patients. With collaborators in Radiology, she has incorporated novel 4D Flow imaging and artificial intelligence (AI) methods to improve targeting and response assessment in CNS vascular lesions. In addition to her imaging research, she is also active in Health Outcomes and Medical Ethics research and has published studies on a wide range of topics including medical device recalls, industry payments to physicians and medical malpractice claims, which have appeared in many prestigious journals including the Journal of the American Medical Association (JAMA). She is an expert reviewer on grant study sections at the National Institutes of Health (NIH). Dr. Hattangadi-Gluth is active in teaching and mentoring undergraduate and graduate students, residents, and post-doctural fellows in the classroom, clinic, and her laboratory, and she has won numerous teaching awards.